INVESTED IN MORE THAN REAL ESTATE. MOTIVATED TO SUPPORT OUR COMMUNITIES.

Bill Koman invests with a commitment to serve and enhance communities, and in support of this mission is involved with numerous philanthropic and community organizations on the West Coast and in the Midwest. Koman has launched various cancer research initiatives and events in San Diego and St. Louis that have raised more than 150 million dollars. These include Curebound, Pedal the Cause-St. Louis and the Frontier Cancer Fund.

CUREBOUND

Curebound is a 501c3 philanthropic organization that raises and invests strategic funding in translational cancer research projects aimed at accelerating new discoveries to clinical application.

Launched in 2021, Curebound represents a partnership and expansion between two highly respected San Diego cancer organizations – Padres Pedal the Cause and the Immunotherapy Foundation—that have raised over $150 million since 2013 to fund more 110+ unique cancer research projects between San Diego’s exceptional research institutions.

Curebound investments in cancer research projects are led by a world-class Scientific Advisory Board (SAB) that aligns deep experience in basic and academic research with industry leaders who bring proven track records in translating basic discoveries to clinical and commercial stages. Under the SAB’s guidance, Curebound curates the most promising research opportunities and brings together highly specialized collaborative teams for each project. Curebound brings together all major cancer research institutes in San Diego including UCSD Moores, the Salk Institute, Sanford Burnham Prebys, Scripps Translational Research, La Jolla Immunology and Rady’s Children’s Hospital.

Curebound is committed to investing more than $100 million into game-changing collaborative cancer research by the end of the decade.

For more information, please visit http: https://www.curebound.org

PEDAL ST. LOUIS

Founded in 2009 by Koman, Pedal the Cause had the goal of creating a community-wide cycling fundraising challenge in which all donations raised would stay in St. Louis and benefit Siteman Cancer Center, Washington University Cancer Researchers and St. Louis Children’s Hospital to provide direct funding for cancer research, including cancer discovery grants and clinical translational care not currently eligible for federal funds. To date, Pedal the Cause has raised approximately 50 million and is St. Louis’s largest community fundraising event. The Komans also led and funded the Illumination Gala and the Cancer Frontier Fund leading to another 50 Million in cancer research funding.

For more information, please visit http://stlouis.pedalthecause.org/